Specialist Updates 
Neurology

Pfizer vax ‘minimal risk’ for patients with Guillain-Barre history

Real-world data from Israel suggest recurrence of the syndrome is rare
Clare Pain
0
16 September 2021
Save
ClosePlease login
Young woman's arm about to be vaccinated

Patients with a history of Guillain-Barré syndrome appear to have a low risk of recurrence if they are vaccinated with Comirnaty, a study of medical records shows.

Doctors from Maccabi Healthcare Services in Tel Aviv, which serves a quarter of the Israeli population, have reported outcomes for 579 patients with a history of Guillain-Barré syndrome (GBS) who subsequently received the mRNA COVID-19 vaccine as guidelines did not contraindicate it.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .